Powering protein degradation for tomorrow’s medicines.

"We are changing the limits of what is possible in medicine. Our vision is to provide a remedy for debilitating diseases that lack effective treatments."

Ying Luo, Ph.D. - C.E.O.

Expanding the drug design paradigm

Targeted Protein Degraders: The ability to drug the “undruggable.”

uSMITE™

Our innovative protein degradation technology featuring novel E3 ligands.

We build the world’s most robust protein degraders using our novel E3 ligands for the treatment of cancer and other debilitating diseases.

Latest News

November 13, 2024

October 8, 2024

January 16, 2024